|
|
||||||||
MUSCLE CELL BIOLOGY AND CELL MOTILITY
1Department of Internal Medicine, Division of Endocrinology, Metabolism, Pathobiochemistry, and Clinical Chemistry, 2Department of Pharmacology, Institute of Pharmacy, and 3Division of Sports Medicine, Medical Clinic, University of Tuebingen, Tuebingen, Germany
Submitted 5 April 2007 ; accepted in final form 2 July 2007
Skeletal muscle cells have been established as significant producers of IL-6 during exercise. This IL-6 production is discussed as one possible mediator of the beneficial effects of physical activity on glucose and fatty acid metabolism. IL-6 itself could be the exercise-related factor that upregulates and maintains its own production. We investigated this hypothesis and the underlying molecular mechanism in cultured C2C12 cells. IL-6 led to a rapid and prolonged increase in IL-6 mRNA, which was also found in human myotubes. Because IL-6 has been shown to activate AMP-activated kinase (AMPK), we studied whether, in turn, activated AMPK induces IL-6 expression. Pharmacological activation of AMPK with 5-aminoimidazole-4-carboxamide-1-
-4-ribofuranoside upregulated IL-6 mRNA expression, which was blocked by knockdown of AMPK
1 and
2 using small, interfering RNA (siRNA) oligonucleotides. However, the effect of IL-6 was shown to be independent of AMPK, since the siRNA approach silencing the AMPK
-subunits did not reduce the upregulation of IL-6 induced by IL-6 stimulation. The self-stimulatory effect of IL-6 partly involves a Ca2+-dependent pathway: IL-6 increased intracellular Ca2+, and intracellular blockade of Ca2+ with a Ca2+ chelator reduced the IL-6-mediated increase in IL-6 mRNA levels. Moreover, inhibition of Ca2+/calmodulin-dependent kinase kinase with STO-609 or the siRNA approach decreased IL-6 mRNA levels of control and IL-6-stimulated cells. A major, STO-609-independent mechanism is the IL-6-mediated stabilization of its mRNA. The data suggest that IL-6 could act as autocrine factor upregulating its mRNA levels, thereby supporting its function as an exercise-activated factor in skeletal muscle cells.
5-aminoimidazole-4-carboxamide-1-
-4-ribofuranoside; AMP-activated kinase; STO-609; calcium/calmodulin-dependent kinase kinase; C2C12 cells
e 10, D-72076 Tuebingen, Germany (e-mail: cora.weigert{at}med.uni-tuebingen.de)This article has been cited by other articles:
![]() |
N. Ichinoseki-Sekine, H. Naito, K. Tsuchihara, I. Kobayashi, Y. Ogura, R. Kakigi, M. Kurosaka, R. Fujioka, and H. Esumi Provision of a voluntary exercise environment enhances running activity and prevents obesity in Snark-deficient mice Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1013 - E1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Meador, C. P. Krzyszton, R. W. Johnson, and K. A. Huey Effects of IL-10 and age on IL-6, IL-1{beta}, and TNF-{alpha} responses in mouse skeletal and cardiac muscle to an acute inflammatory insult J Appl Physiol, April 1, 2008; 104(4): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |